Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL: Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993, 328: 246-252. 10.1056/NEJM199301283280406.
Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC: Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA. 1998, 280: 1569-1575. 10.1001/jama.280.18.1569.
Barnes PM, Powell-Griner E, McFann K, Nahin RL: Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004, 1-19.
Tindle HA, Davis RB, Phillips RS, Eisenberg DM: Trends in use of complementary and alternative medicine by US adults: 1997–2002. Altern Ther Health Med. 2005, 11: 42-49.
Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA: Complementary and alternative medicine use among adults with diabetes in the United States. Altern Ther Health Med. 2006, 12: 16-22.
Grzywacz JG, Suerken CK, Quandt SA, Bell RA, Lang W, Arcury TA: Older adults' use of complementary and alternative medicine for mental health: findings from the 2002 National Health Interview Survey. J Altern Complement Med. 2006, 12: 467-473. 10.1089/acm.2006.12.467.
Carlson MJ, Krahn G: Use of complementary and alternative medicine practitioners by people with physical disabilities: estimates from a National US Survey. Disabil Rehabil. 2006, 28: 505-513. 10.1080/09638280500212062.
Saydah SH, Eberhardt MS: Use of complementary and alternative medicine among adults with chronic diseases: United States 2002. J Altern Complement Med. 2006, 12: 805-812. 10.1089/acm.2006.12.805.
Pearson NJ, Johnson LL, Nahin RL: Insomnia, trouble sleeping, and complementary and alternative medicine: Analysis of the 2002 national health interview survey data. Arch Intern Med. 2006, 166: 1775-1782. 10.1001/archinte.166.16.1775.
Kessler RC, Soukup J, Davis RB, Foster DF, Wilkey SA, Van Rompay MM, Eisenberg DM: The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry. 2001, 158: 289-294. 10.1176/appi.ajp.158.2.289.
Kennedy J: Herb and supplement use in the US adult population. Clin Ther. 2005, 27: 1847-1858. 10.1016/j.clinthera.2005.11.004.
Gardiner P, Graham R, Legedza AT, Ahn AC, Eisenberg DM, Phillips RS: Factors associated with herbal therapy use by adults in the United States. Altern Ther Health Med. 2007, 13: 22-29.
Robbins JM, Cleves MA, Collins HB, Andrews N, Smith LN, Hobbs CA: Randomized trial of a physician-based intervention to increase the use of folic acid supplements among women. Am J Obstet Gynecol. 2005, 192: 1126-1132. 10.1016/j.ajog.2004.10.620.
Sibinga EM, Ottolini MC, Duggan AK, Wilson MH: Parent-pediatrician communication about complementary and alternative medicine use for children. Clin Pediatr (Phila). 2004, 43: 367-373.
Busse JW, Heaton G, Wu P, Wilson KR, Mills EJ: Disclosure of natural product use to primary care physicians: a cross-sectional survey of naturopathic clinic attendees. Mayo Clin Proc. 2005, 80: 616-623.
Bent S, Ko R: Commonly used herbal medicines in the United States: a review. Am J Med. 2004, 116: 478-485. 10.1016/j.amjmed.2003.10.036.
Beal T, Kemper KJ, Gardiner P, Woods C: Long-term impact of four different strategies for delivering an on-line curriculum about herbs and other dietary supplements. BMC Med Educ. 2006, 6: 39-10.1186/1472-6920-6-39.
Cohen MH, Hrbek A, Davis RB, Schachter SC, Kemper KJ, Boyer EW, Eisenberg DM: Emerging credentialing practices, malpractice liability policies, and guidelines governing complementary and alternative medical practices and dietary supplement recommendations: a descriptive study of 19 integrative health care centers in the United States. Arch Intern Med. 2005, 165: 289-295. 10.1001/archinte.165.3.289.
Eisenberg DM: Advising patients who seek alternative medical therapies. Ann Intern Med. 1997, 127: 61-69.
Gardiner P, Graham RE, Legedza AT, Eisenberg DM, Phillips RS: Factors associated with dietary supplement use among prescription medication users. Arch Intern Med. 2006, 166: 1968-1974. 10.1001/archinte.166.18.1968.
Kemper KJ, Gardiner P, Gobble J, Woods C: Expertise about herbs and dietary supplements among diverse health professionals. BMC Complement Altern Med. 2006, 6: 15-10.1186/1472-6882-6-15.
Manheimer E, Berman B: NCCAM support for the Cochrane Collaboration CAM Field. Complement Ther Med. 2003, 11: 268-271. 10.1016/S0965-2299(03)00128-6.
Liu Y, Doucette WR, Farris KB, Nayakankuppam D: Drug information-seeking intention and behavior after exposure to direct-to-consumer advertisement of prescription drugs. Res Social Adm Pharm. 2005, 1: 251-269.
Lyles A: Direct marketing of pharmaceuticals to consumers. Annu Rev Public Health. 2002, 23: 73-91. 10.1146/annurev.publhealth.23.100901.140537.
Smith R: Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med. 2005, 2: e138-10.1371/journal.pmed.0020138.
Lexchin J: Interactions between physicians and the pharmaceutical industry: what does the literature say?. CMAJ. 1993, 149: 1401-1407.
Epstein RA: Influence of pharmaceutical funding on the conclusions of meta-analyses. Bmj. 2007, 335: 1167-10.1136/bmj.39381.655845.BE.
Tsai AC: Conflicts between commercial and scientific interests in pharmaceutical advertising for medical journals. Int J Health Serv. 2003, 33: 751-768. 10.2190/K0JG-EXG1-FB12-0ANF.
Brennan TA, Rothman DJ, Blank L, Blumenthal D, Chimonas SC, Cohen JJ, Goldman J, Kassirer JP, Kimball H, Naughton J, Smelser N: Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006, 295: 429-433. 10.1001/jama.295.4.429.
Coleman DL, Kazdin AE, Miller LA, Morrow JS, Udelsman R: Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach. Acad Med. 2006, 81: 154-160. 10.1097/00001888-200602000-00011.
Lo B, Wolf LE, Berkeley A: Conflict-of-interest policies for investigators in clinical trials. N Engl J Med. 2000, 343: 1616-1620. 10.1056/NEJM200011303432206.
Kirch DG: Conflict-of-interest management: efforts and insights from the Association of American Medical Colleges. Cleve Clin J Med. 2007, 74 (Suppl 2): S23-25. discussion S32-27.
Jacobson MF, Sharpe VA, Angell M, Ashford NA, Blum A, Chary LK, Cho M, Coull BC, Davis D, Doolittle RF: Editorial policies on financial disclosure. Nat Neurosci. 2003, 6: 1001-10.1038/nn1003-1001.
Lexchin J, Light DW: Commercial influence and the content of medical journals. BMJ. 2006, 332: 1444-1447. 10.1136/bmj.332.7555.1444.
McFadden DW, Calvario E, Graves C: The devil is in the details: the pharmaceutical industry's use of gifts to physicians as marketing strategy. J Surg Res. 2007, 140: 1-5. 10.1016/j.jss.2006.10.010.
Wazana A: Physicians and the pharmaceutical industry: is a gift ever just a gift?. JAMA. 2000, 283: 373-380. 10.1001/jama.283.3.373.
Wilkes MS, Kravitz RL: Policies, practices, and attitudes of North American medical journal editors. J Gen Intern Med. 1995, 10: 443-450. 10.1007/BF02599916.
Friedman L, Richter ED: Conflicts of interest and scientific integrity. Int J Occup Environ Health. 2005, 11: 205-206.
Buettner C, Phillips RS, Davis RB, Gardiner P, Mittleman MA: Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks. Am J Cardiol. 2007, 99: 661-666. 10.1016/j.amjcard.2006.09.116.
NIH State-of-the-Science Conference Statement on Multivitamin/Mineral Supplements and Chronic Disease Prevention. NIH Consens State Sci Statements. 2006, 23: 1-30.
North American Menopause Society: The role of calcium in peri- and postmenopausal women 2006 position statement of the North American Menopause Society. Menopause. 2006, 13: 862-877. 10.1097/01.gme.0000243566.25205.0b. quiz 878–880.
Sood A, Knudsen K, Sood R, Wahner-Roedler DL, Barnes SA, Bardia A, Bauer BA: Publication bias for CAM trials in the highest impact factor medicine journals is partly due to geographical bias. J Clin Epidemiol. 2007, 60: 1123-1126. 10.1016/j.jclinepi.2007.01.009.